Evotec SE ADR (EVO) - Total Liabilities

Latest as of March 2026: $941.17 Million USD

Based on the latest financial reports, Evotec SE ADR (EVO) has total liabilities worth $941.17 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EVO long-term investments to assets to see how much of total assets are deployed in long-term investments.

Evotec SE ADR - Total Liabilities Trend (2003–2025)

This chart illustrates how Evotec SE ADR's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see EVO total asset value.

Evotec SE ADR Competitors by Total Liabilities

The table below lists competitors of Evotec SE ADR ranked by their total liabilities.

Company	Country	Total Liabilities
Air Global PLC Ordinary Shares NASDAQ:AIIR	USA	$566.31 Million
SIGNATUREGLOBAL (INDIA) LIMITED NSE:SIGNATURE	India	Rs138.47 Billion
Nantong Jiangshan Agrochemical & Chemicals Co Ltd SHG:600389	China	CN¥5.07 Billion
Chengdu Haoneng Tech Co Ltd SHG:603809	China	CN¥3.18 Billion
Netcare JSE:NTC	South Africa	ZAC18.24 Billion
Universal Technical Institute Inc NYSE:UTI	USA	$553.56 Million
ITMAX System Berhad KLSE:5309	Malaysia	RM140.04 Million
Atresmedia Corporación de Medios de Comunicación S.A. MC:A3M	Spain	€730.78 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Evotec SE ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Evotec SE ADR balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Evotec SE ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Evotec SE ADR (2003–2025)

The table below shows the annual total liabilities of Evotec SE ADR from 2003 to 2025.

Year	Total Liabilities	Change
2025-12-31	$964.64 Million	+0.49%
2024-12-31	$959.98 Million	-18.59%
2023-12-31	$1.18 Billion	+10.19%
2022-12-31	$1.07 Billion	+24.79%
2021-12-31	$857.48 Million	-9.86%
2020-12-31	$951.26 Million	+12.66%
2019-12-31	$844.39 Million	+143.34%
2018-12-31	$347.00 Million	+3.42%
2017-12-31	$335.52 Million	+144.14%
2016-12-31	$137.43 Million	+35.47%
2015-12-31	$101.44 Million	+53.20%
2014-12-31	$66.22 Million	-3.21%
2013-12-31	$68.41 Million	-6.13%
2012-12-31	$72.88 Million	+2.69%
2011-12-31	$70.97 Million	+19.83%
2010-12-31	$59.22 Million	+68.67%
2009-12-31	$35.11 Million	+6.27%
2008-12-31	$33.04 Million	-11.48%
2007-12-31	$37.33 Million	-45.39%
2006-12-31	$68.35 Million	+82.55%
2005-12-31	$37.44 Million	+307.75%
2004-12-31	$9.18 Million	+61.18%
2003-12-31	$5.70 Million	--

About Evotec SE ADR

NASDAQ:EVO USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

Market Cap Rank

#8315 Global

#2431 in USA

Share Price

$3.23

Change (1 day)

-2.12%

52-Week Range

$2.31 - $4.73

All Time High

$26.53